You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (59)

Journals (0)

1-10 of 59 results for Programmed death receptor-1 inhibitor therapy

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Behcet’s-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy

Retricted access

Case report

First published 2020-6

Behcet’s-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy

Steffi Thomas, Chay Bae, Tabanor Joy-Ann [...]

Journal of Oncology Pharmacy Practice

Select article: Nivolumab-induced aplastic anemia: A case report and literature review

Retricted access

Case report

First published 2019-1

Nivolumab-induced aplastic anemia: A case report and literature review

Rachel R Comito, Lynette A Badu, Nicholas Forcello

Journal of Oncology Pharmacy Practice

Select article: Adverse effects of immune checkpoint inhibitor therapies on right ventricular function and pulmonary arterial dilatation

Open access

Research article

First published 2021-1

Adverse effects of immune checkpoint inhibitor therapies on right ventricular function and pulmonary arterial dilatation

Ruben Mylvaganam, Ryan Avery, Isaac Goldberg [...]

Pulmonary Circulation

Select article: Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Open access

Review article

First published 2024

Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Yuehua Liang, Xiaoran Liu, Zehui Yun [...]

Therapeutic Advances in Medical Oncology

Select article: Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions

Retricted access

Research article

First published 2019-6

Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions

Bellinda L King-Kallimanis, Lynn J Howie, Jessica K Roydhouse [...]

Clinical Trials

Select article: Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

Free access

Review article

First published 2017-4

Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

Che-Kai Tsao, Bobby Liaw, Catherine He [...]

Therapeutic Advances in Medical Oncology

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: An exploration of the initiation time and patient selection of PD-1 inhibitors/PD-1 inhibitors combined with chemotherapy as salvage therapy in R/R DLBCL patients after anti-CD19-CAR T-cell therapy

Open access

Research article

First published 2025

An exploration of the initiation time and patient selection of PD-1 inhibitors/PD-1 inhibitors combined with chemotherapy as salvage therapy in R/R DLBCL patients after anti-CD19-CAR T-cell therapy

Xin Li, Juan Mu, Jia Wang [...]

Cell Transplantation

Select article: Immune Checkpoint Inhibitor Therapy in Colorectal Cancer—The Role of Cellular Pathology

Retricted access

Review article

First published 2021-9

Immune Checkpoint Inhibitor Therapy in Colorectal Cancer—The Role of Cellular Pathology

Adrian C. Bateman

International Journal of Surgical Pathology

Select article: Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report

Retricted access

Case report

First published 2017-12

Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report

Lindsay A Edmondson, Leticia V Smith, Alka Mallik

Journal of Oncology Pharmacy Practice

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access